US Patent Issued to Novocure on Oct. 14 for "Methods of treating disease by skewing macrophage phenotype with alternating electric fields" (Israeli Inventors)

ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,440,680, issued on Oct. 14, was assigned to Novocure GmbH (Baar, Switzerland).

"Methods of treating disease by skewing macrophage phenotype with alternating electric fields" was invented by Tali Voloshin-Sela (Kibbutz Gvat, Israel), Lilach Avigdor (Haifa, Israel) and Boris Brant (Haifa, Israel).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods of treating diseases and infections by applying alternating electric fields to tissues followed by administering a treatment for the disease or infection are provided. In some instances, alternating electric fields can be applied at least until substantial improvement in disease manifestation. The exemplary me...